PIRS
Closed
Pieris Pharmaceuticals Inc
13.26
-0.34 (-2.50%)
Last Update: 14 Dec 2024 00:03:00
Yesterday: 13.6
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.78
Pieris Pharmaceuticals Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative therapies for the treatment of cancer and other diseases. The company's proprietary Anticalin platform allows for the development of highly specific and potent therapeutic proteins that can target a wide range of disease targets. Pieris Pharmaceuticals is headquartered in Boston, Massachusetts, and has additional operations in Germany. The company was founded in 2001 and went public in 2014. Its pipeline includes several drug candidates in clinical and preclinical development for the treatment of various cancers, respiratory diseases, and other indications. Pieris Pharmaceuticals has partnerships with several pharmaceutical companies, including AstraZeneca, Servier, and Daiichi Sankyo.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








